Skip to content

Absci Corporation ABSI Finance Lease, Principal Payments

Finance Lease, Principal Payments at other companies

Schrodinger logo
SchrodingerSDGR
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's finance lease, principal payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's finance lease, principal payments?
Absci Corporation (ABSI) reported finance lease, principal payments of $0 in Q1 2026.
How has Absci Corporation's finance lease, principal payments changed year-over-year?
Absci Corporation's finance lease, principal payments decreased by 100.0% year-over-year, from $47K to $0.
What is the long-term trend for Absci Corporation's finance lease, principal payments?
Over 4 years (2021 to 2025), Absci Corporation's finance lease, principal payments has grown at a -58.0% compound annual growth rate (CAGR), from $2.55M to $79K.